Sökning: "Mild cognitive impairment MCI"
Visar resultat 1 - 5 av 63 avhandlingar innehållade orden Mild cognitive impairment MCI.
1. Hippocampal volumetry in mild cognitive impairment
Sammanfattning : Dementia is a syndrome with cognitive decline as a prominent feature. MCI is similarly a syndrome of cognitive decline, albeit with much subtler symptoms, and has been identified as a condition at risk for progression to dementia. A considerable clinical challenge lies in identifying MCI patients with an underlying dementia disorder. LÄS MER
2. Validation of brief cognitive tests in mild cognitive impairment, Alzheimer's disease and dementia with Lewy bodies
Sammanfattning : Background It is estimated that 34 million people suffer from dementia, costing society US$422 billion each year. Alzheimer’s disease (AD) is the most common dementia and the global prevalence is predicted to increase to over 100 million people by the year 2050, with the greatest increase in developing countries. LÄS MER
3. Cognitive profiles of vascular and neurodegenerative MCI
Sammanfattning : The objective of the thesis was to investigate the cognitive profiles of different types of mild cognitive impairment (MCI) and follow their course over time. Would it be possible to differentiate between ?benign? and ?malign? forms of MCI, and identify different dementia disorders in their prodromal stages by means of cognitive profiles? In study I consecutive MCI subjects (N=112) were assessed with a neuropsyhological test battery of 21 tests. LÄS MER
4. Cognitive impairment and its consequences in everyday life
Sammanfattning : The overall aim was to improve knowledge of the consequences of cognitive dysfunction in everyday life and of instruments to make these assessments. The thesis contains four studies each of different design using different populations. LÄS MER
5. Prediction of Alzheimer’s disease in subjects with Mild Cognitive Impairment using biomarkers
Sammanfattning : Background: Alzheimer’s disease (AD) is the most common cause of dementia. In order to have effect of future disease-modifying therapies for AD, the disease must be identified early, before the patients have developed dementia. Many patients with Mild Cognitive Impairment (MCI) have prodromal AD, but other causes for the syndrome are common. LÄS MER